Oncotelic Therapeutics, Inc.
PublicOncotelic Therapeutics, Inc. is now publicly traded
The data on this page reflects Oncotelic Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Grant
Jul 10, 2026
Total Funding Raised
$14.01M
Company Overview
Oncotelic Therapeutics, Inc. operates in Healthcare and is based in the United States. It has raised $14.01M.
Oncotelic Therapeutics, Inc. is a biopharmaceutical company that develops RNA-based, immunotherapy, and targeted therapeutics for the treatment of cancer and other rare diseases.
Sector
Healthcare
AI Layer
Application
Oncotelic Therapeutics, Inc. Comparables
Compare Oncotelic Therapeutics, Inc. with similar companies based on industry and business-model similarity.
No comparables are published for Oncotelic Therapeutics, Inc.. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Oncotelic Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 10, 2026 | ||||
| Private Placement | Dec 4, 2025 | ||||
| Private Placement | Jul 23, 2020 | ||||
| Private Placement | Apr 22, 2019 | ||||
| Private Placement | Apr 12, 2018 | ||||
Private Placement | Mar 12, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oncotelic Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.